Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Effrosyni Sianou"'
Autor:
Eva Tzelepi, A. F. Koutinas (Α.Φ. Κουτινασ), Elpida I. Vingopoulou, M. N. Saridomichelakis, Victoria I. Siarkou, F. Kaltsogianni, G.C. Batzias, Vivi Miriagou, I. Tzavaras, Danai Sofianou, Effrosyni Sianou
Publikováno v:
Journal of Antimicrobial Chemotherapy. 69:2076-2080
OBJECTIVES To characterize the mechanisms implicated in fluoroquinolone (FQ) and expanded-spectrum cephalosporin (ESC) resistance in three clinical and seven faecal multidrug-resistant (MDR; resistant to at least three antimicrobial classes) Escheric
Autor:
Spiros Miyakis, Michael Petridis, Danai Sofianou, Georgios Meletis, Effrosyni Sianou, Ioulia Kristo, Kyriakos Apostolidis
Publikováno v:
Journal of Antimicrobial Chemotherapy. 67:244-246
Department of Clinical Microbiology, Hippokration Hospital, Thessaloniki, Greece; Department of Microbiology, Medical School, University of Thessaly, Larissa, Greece; Laboratory of Parasitology, School of Veterinary Medicine, Aristotle University of
Publikováno v:
Journal of Antimicrobial Chemotherapy. 66:946-947
Sir, Klebsiella pneumoniae is an important pathogen that causes severe and life-threatening infections. Most isolates demonstrate resistance to various antimicrobial agents. Carbapenems have been widely used to treat serious infections with multidrug
Autor:
Elias Iosifidis, E Protonotariou, V Dimou, Emmanuel Roilides, A Zagorianou, Effrosyni Sianou, Spiros Miyakis, Danai Sofianou
Publikováno v:
Scopus-Elsevier
We report 570 carbapenemase-producing Klebsiella pneumoniae (CPKP) clinical isolates in a 1,040-bed Greek tertiary hospital during 2004 to 2010. The first CPKP (VIM-producing) was isolated in September 2004. Despite initial containment, VIM producers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3fb5868ee4afe165208dda4cd4e99d6
http://www.scopus.com/inward/record.url?eid=2-s2.0-84857419846&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84857419846&partnerID=MN8TOARS